Issue: In light of the COVID-19 pandemic, global infections have surpassed 290 million with reported fatalities reaching 5 million. The strain on healthcare resources has led to the postponement or cancellation of critical healthcare services, including chronic disease management, cancer screening, and treatments. Consequently, there has been a decline in referrals for suspected cancers, raising concerns about increased cancer-related mortality.
Objective: Our aim is to conduct thorough research to assess the impact of the COVID-19 pandemic on patients diagnosed with primary liver cancer (PLC).
Product: We have undertaken comprehensive research to analyze the factors directly influencing the development of liver cancer. The finalized machine learning model incorporates various variables, including smoking habits, levels of anxiety, presence of chronic diseases, allergies, respiratory symptoms such as wheezing and coughing, fatigue, alcohol consumption, as well as specific symptoms like difficulty in swallowing and chest pain.
Solution: Our ultimate solution involves identifying key factors significantly contributing to the development of liver cancer and pinpointing high-risk groups within the population.
Market Advantage: The outcomes of our research project can serve as a foundation for devising effective strategies to mitigate factors leading to liver cancer among high-risk populations during pandemics. This enables the maintenance of medical service efficiency even in crisis periods while ensuring appropriate treatment protocols for affected patients.
Objective: Our aim is to conduct thorough research to assess the impact of the COVID-19 pandemic on patients diagnosed with primary liver cancer (PLC).
Product: We have undertaken comprehensive research to analyze the factors directly influencing the development of liver cancer. The finalized machine learning model incorporates various variables, including smoking habits, levels of anxiety, presence of chronic diseases, allergies, respiratory symptoms such as wheezing and coughing, fatigue, alcohol consumption, as well as specific symptoms like difficulty in swallowing and chest pain.
Solution: Our ultimate solution involves identifying key factors significantly contributing to the development of liver cancer and pinpointing high-risk groups within the population.
Market Advantage: The outcomes of our research project can serve as a foundation for devising effective strategies to mitigate factors leading to liver cancer among high-risk populations during pandemics. This enables the maintenance of medical service efficiency even in crisis periods while ensuring appropriate treatment protocols for affected patients.